Seon-Yeong Lee

Seon-Yeong Lee

Auto-generated profile, based on publicly available information

Seon-Yeong Lee

The Rheumatism Research Center, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SLSeon-Yeong Lee
Seon-Yeong Lee
SMSu-Jin Moon
Su-Jin Moon
EKEun-Kyung Kim
Eun-Kyung Kim
HSHyeon-Beom Seo
Hyeon-Beom Seo
EYEun-Ji Yang
Eun-Ji Yang
Mi-La ChoMi-La Cho
Mi-La Cho
Circulating autoantibodies and immune complex deposition are pathological hallmarks of systemic lupus erythematosus (SLE). B cell differentiation into plasma cells (PCs) and some T cell subsets that function as B cell helpers can be therapeutic targets of SLE. Mechanistic target of rapamycin (mTOR) signaling is implicated in the formation of B cells and germinal centers (GCs). We assessed the effect of metformin, which inhibits mTOR, on the development of autoimmunity using Roquinsan/san mice. Oral administration of metformin inhibited the formation of splenic follicles and inflammation in kidney and liver tissues. It also decreased serum levels of anti-dsDNA Abs without affecting serum glucose levels. Moreover, metformin inhibited CD21highCD23low marginal zone B cells, B220+GL7+ GC B cells, B220−CD138+ PCs, and GC formation. A significant reduction in ICOS+ follicular helper T cells was found in the spleens of the metformin-treated group compared with the vehicle-treated group. In addition, metformin inhibited Th17 cells and induced regulatory T cells. These alterations in B and T cell subsets by metformin were associated with enhanced AMPK expression and inhibition of mTOR–STAT3 signaling. Furthermore, metformin induced p53 and NF erythroid-2–related factor-2 activity in splenic CD4+ T cells. Taken together, metformin-induced alterations in AMPK–mTOR–STAT3 signaling may have therapeutic value in SLE by inhibiting B cell differentiation into PCs and GCs.

15 February 2017 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
HSHye-Jin Son
Hye-Jin Son
SLSeung Hoon Lee
Seung Hoon Lee
SLSeon-Yeong Lee
Seon-Yeong Lee
EKEun-Kyung Kim
Eun-Kyung Kim
EYEun-Ji Yang
Eun-Ji Yang
Mi-La ChoMi-La Cho
Mi-La Cho
Oncostatin M (OSM) is a pleiotropic cytokine and a member of the IL-6 family. It has both proinflammatory and anti-inflammatory functions and is involved in the activation of STAT3 and STAT5. Rheumatoid arthritis is an autoimmune disease that causes chronic and excessive inflammation. Rheumatoid arthritis can lead to induction of Th17 cells, which express IL-17. The aim of this study was to measure the effects of OSM on the proliferation of regulatory T cells and Th17 cells from mice. IL-2 immune complex suppressed the development of collagen-induced arthritis in mice and altered the regulatory T/Th17 cell balance by increasing OSM expression. OSM mitigated the proliferation of Th17 cells and decreased the expression of IL-17 and IL-21. It promoted the activation of suppressor of cytokine signaling 3 (SOCS3), STAT3, and STAT5. Inhibition of SOCS3, STAT3, and STAT5 lessened the OSM-induced reduction in proliferation of Th17 cells. These observations suggest that OSM can inhibit Th17 differentiation by reciprocally controlling SOCS3, STAT3, and STAT5.

1 January 2021 in Immune Network
Verified
Journal Article
Open access
PDF file
HMHong Ki Min
Hong Ki Min
JMJeonghyeon Moon
Jeonghyeon Moon
SLSeon-Yeong Lee
Seon-Yeong Lee
ALA Ram Lee
A Ram Lee
CLChae Rim Lee
Chae Rim Lee
SPSung-Hwan Park
Sung-Hwan Park
Min HK, et al. Immune Netw. 2021 Nov;21(6):e43. https://doi.org/10.4110/in.2021.21.e43

1 November 2025 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
HLHanbi Lee
Hanbi Lee
YSYoo-Jin Shin
Yoo-Jin Shin
XFXianying Fang
Xianying Fang
SCSheng Cui
Sheng Cui
SLSun Woo Lim
Sun Woo Lim
BCByung Ha Chung
Byung Ha Chung
Background: The aim of this study is to investigate the specific pathway involved in human leukocyte antigen (HLA) sensitization using single-cell RNA-sequencing analysis and an allo-sensitized mouse model developed with an HLA.A2 transgenic mouse. Methods: For sensitization, wild-type C57BL/6 mouse received two skin grafts from C57BL/6-Tg(HLA-A2.1)1Enge/J mouse (allogeneic mouse, ALLO). For syngeneic control (SYN), skin grafts were transferred from C57BL/6 to C57BL/6. We performed single-cell RNA-sequencing analysis on splenocytes isolated from ALLO and SYN and compared the gene expression between them.Results: We generated 9,190 and 8,890 single-cell transcriptomes from ALLO and SYN, respectively. Five major cell types (B cells, T cells, natural killer cells, macrophages, and neutrophils) and their transcriptome data were annotated according to the representative differentially expressed genes of each cell cluster. The percentage of B cells was higher in ALLO than it was in SYN. Kyoto Encyclopedia of Genes and Genomes enrichment analyses indicated that the highly expressed genes in the B cells from ALLO were mainly associated with antigen processing and presentation pathways, allograft rejection, and the Th17 cell differentiation pathway. Upregulated genes in the T cells of ALLO were involved in the interleukin (IL)-17 signaling pathway. The ratio of Th17 cluster and Treg cluster was increased in the ALLO. On flow cytometry, the percentage of Th17 (IL-17+/CD4+ T) cells was higher and regulatory T cells (FOXP3+/CD4+ T) was lower in the ALLO compared to those in the SYN.Conclusion: Our results indicate that not only the B cell lineage but also the Th17 cells and their cytokine (IL-17) are involved in the sensitization to HLA.

1 January 2025 in Immune Network
Verified
Journal Article
Open access
PDF file
HNHyun Sik Na
Hyun Sik Na
SLSeon-Young Lee
Seon-Young Lee
Dong hwan LeeDong hwan Lee
Dong hwan Lee
KCKeun-Hyung Cho
Keun-Hyung Cho
SKSeon Ae Kim
Seon Ae Kim
SKSeok Jung Kim
Seok Jung Kim
Na HS, et al. Immune Netw. 2025 Jun;25(3):e24. https://doi.org/10.4110/in.2025.25.e24